Elite in Insomnia

Dr. Clete A. Kushida

Sleep Medicine
450 Broadway St, 
Redwood City, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Elite in Insomnia
450 Broadway St, 
Redwood City, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Clete Kushida is a Sleep Medicine provider in Redwood City, California. Dr. Kushida is rated as an Elite provider by MediFind in the treatment of Insomnia. His top areas of expertise are Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, Adenoidectomy, and Deep Brain Stimulation.

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles and participated in 1 clinical trial in the study of Insomnia.

Specialties
Sleep Medicine
Licenses
Psychiatry & Neurology in CA
Hospital Affiliations
Stanford Health Care
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

STANFORD HEALTH CARE
450 Broadway St, Redwood City, CA 94063
Other Locations
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA 94305

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair
Enrollment Status: Recruiting
Publish Date: July 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 19, 2025
Intervention Type: Other, Device
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
Effects of Positive Airway Pressure on Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Atrial Fibrillation and Obstructive Sleep Apnea-A Pilot Randomized Controlled Trial
Effects of Positive Airway Pressure on Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Atrial Fibrillation and Obstructive Sleep Apnea-A Pilot Randomized Controlled Trial
Enrollment Status: Withdrawn
Publish Date: May 24, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Multicenter Open-Label Extension Study to Evaluate the Efficacy and Safety of HORIZANT (Gabapentin Enacarbil) Extended-Release Tablets in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary Restless Legs Syndrome
A Multicenter Open-Label Extension Study to Evaluate the Efficacy and Safety of HORIZANT (Gabapentin Enacarbil) Extended-Release Tablets in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary Restless Legs Syndrome
Enrollment Status: Unknown
Publish Date: June 09, 2021
Intervention Type: Drug
Study Drug: Gabapentin Enacarbil
Study Phase: Phase 4
A Multicenter, Double-Blind, Placebo Controlled, Parallel Group, Efficacy and Safety Evaluation of HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary RLS
A Multicenter, Double-Blind, Placebo Controlled, Parallel Group, Efficacy and Safety Evaluation of HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary RLS
Enrollment Status: Unknown
Publish Date: June 09, 2021
Intervention Type: Drug
Study Drug: Gabapentin Enacarbil
Study Phase: Phase 4
A Study on Realization of Objective Evaluation Method of Depression Using Sleep EEG
A Study on Realization of Objective Evaluation Method of Depression Using Sleep EEG
Enrollment Status: Completed
Publish Date: December 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
Treatments for Insomnia: Mediators, Moderators and Quality of Life
Treatments for Insomnia: Mediators, Moderators and Quality of Life
Enrollment Status: Completed
Publish Date: September 20, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
View 11 Less Clinical Trials

164 Total Publications

The American academy of sleep medicine position statement on sleepiness: A world sleep society international sleep medicine practice recommendations committee perspective.
The American academy of sleep medicine position statement on sleepiness: A world sleep society international sleep medicine practice recommendations committee perspective.
Journal: Sleep medicine
Published: August 06, 2025
Similar Doctors
Advanced in Insomnia
Dr. Scott J. Kutscher
Sleep Medicine | Neurology
Advanced in Insomnia
Dr. Scott J. Kutscher
Sleep Medicine | Neurology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (3.9 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Kutscher is a Sleep Medicine specialist and a Neurologist in Stanford, California. Dr. Kutscher is rated as an Advanced provider by MediFind in the treatment of Insomnia. His top areas of expertise are Obstructive Sleep Apnea, Insomnia, Restless Legs Syndrome, and REM Behavior Disorder. Dr. Kutscher is currently accepting new patients.

Distinguished in Insomnia
Dr. David M. Claman
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Distinguished in Insomnia
Dr. David M. Claman
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Regents Of The University Of California

2330 Post St, 
San Francisco, CA 
 (24.4 miles away)
415-476-4029
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Claman is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in San Francisco, California. Dr. Claman is rated as a Distinguished provider by MediFind in the treatment of Insomnia. His top areas of expertise are Obstructive Sleep Apnea, Insomnia, Central Sleep Apnea, and Lung Metastases.

Michelle M. Primeau
Advanced in Insomnia
Dr. Michelle M. Primeau
Sleep Medicine
Advanced in Insomnia
Dr. Michelle M. Primeau
Sleep Medicine

San Carlos Center

301 Industrial Road, Level 3, 
San Carlos, CA 
 (3.8 miles away)
650-632-0820
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michelle Primeau is a Sleep Medicine provider in San Carlos, California. Dr. Primeau is rated as an Advanced provider by MediFind in the treatment of Insomnia. Her top areas of expertise are Obstructive Sleep Apnea, Insomnia, Irregular Sleep-Wake Syndrome, and Excessive Daytime Sleepiness. Dr. Primeau is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kushida's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile